Document is current

Article History

Accepted: 17 February 2025

First Online: 1 March 2025

Declarations

:

: Open access funding provided by Copenhagen University. No external funding was received for the preparation of this article.

: Christine E. Hallgreen is an employee of the Copenhagen Centre for Regulatory Sciences (CORS), Department of Pharmacy, University of Copenhagen. CORS is a cross-faculty university-anchored institution involving various public (Danish Medicines Agency, Copenhagen University) and private stakeholders (Novo Nordisk, Lundbeck, Ferring Pharmaceuticals, LEO Pharma) as well as patient organisations (Rare Diseases Denmark). The centre is purely devoted to the scientific aspects of the regulatory field and has a patient-oriented focus, and the research is not related to a company-specific product or directly company related. In the last 3 years, CORS and Christine E. Hallgreen have received funding from Novo Nordisk for projects not related to this study. Per Sindahl is employed by the Danish Medicines Agency and a guest researcher at CORS. At the time of the project, Per Sindahl was also a PhD fellow at the Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University. Morten Andersen is an employee at the Department of Drug Design and Pharmacology, University of Copenhagen. His Professorship and the Pharmacovigilance Research Centre were funded by a grant from the Novo Nordisk Foundation to the University during 2016–22. He has previously participated in research projects funded by AstraZeneca, H. Lundbeck & Mertz, Janssen, Novartis, Merck Sharp & Dohme and Pfizer, with grants paid to the institutions where he was employed, and personally has received fees from Atrium, the Danish Pharmaceutical Industry Association, for leading and teaching pharmacoepidemiology courses. Haoxin Le is a PhD student at CORS, and has no conflicts of interest that are directly relevant to the content of this article. The authors declare no other known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

: Not applicable.

: Not applicable.

: Not applicable.

: Data used for this article are available at .

: Not applicable.

: HL: writing (review and editing), writing (original draft), visualisation, methodology, investigation, formal analysis, data curation, conceptualisation. PS: writing (review and editing), investigation. MA: writing (review and editing), conceptualisation, supervision. CEH: writing (review and editing), validation, supervision, resources, project administration, methodology, investigation, conceptualisation. All authors have read and approved the final version.